Ranbaxy shares fell again today in London on news that the U.S. government is investigating the Indian generics giant.
The feds are looking into whether the company manufactured substandard drugs, including those given to HIV patients in Africa as part of a U.S.-funded program, the WSJ reports.
U.S. investigators are looking into possible fraud, false claims and [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment